# Medtronic

Organization · id `cardio:medtronic` · Cardiovascular Atlas · release `f6f6f1b6f50379ed` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Medtronic, Inc.; Medtronic Cardiovascular

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A company based in the United States (ROR types: company and funder). US regulatory records name Medtronic, Inc. as the applicant for the approvals of the CoreValve and Evolut heart valves and the Melody pulmonary valve. ClinicalTrials.gov names Medtronic Cardiovascular as the lead sponsor of the Evolut Low Risk trial, and the PubMed abstract says Medtronic funded it.

## Technical summary

Research Organization Registry record 00grd1h17, named Medtronic (United States), type company and funder. openFDA PMA records P130021 and P140017 name Medtronic, Inc. as the applicant. The registry names Medtronic Cardiovascular, class industry, as lead sponsor of NCT02701283. The sources read do not say how the names Medtronic, Inc. and Medtronic Cardiovascular relate to each other or to the registry record, and this atlas does not say.

## Connected pages

- Manufactures: CoreValve and Evolut transcatheter valves (`cardio:corevalve-evolut`)
- Manufactures: Melody transcatheter pulmonary valve (`cardio:melody-transcatheter-pulmonary-valve`)
- Funds: DANISH (`cardio:danish-trial`)
- Sponsors: Evolut Low Risk trial (`cardio:evolut-low-risk`)
- Funds: Evolut Low Risk trial (`cardio:evolut-low-risk`)

## Provenance

Content hash: e0dafc5741c0dc20e3e5de627f9881db01c61f08bdad857b8a11b367152c54c2
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-14